dual glp-1/gip agonist Tirzepatide's Unique Mechanism of Action GIPR/GLP-1R dual agonist therapies for
Description
doi: 10.16438/j.0513-4870.2019-0212 15

and Novo Nordisk and has received support for attending meetings and/or travel from Eli Lilly & Co

Psychiatry 4 , e458
There was no clinical focus for this at all
(4) study design: RCT published in full text

J Diabetes Invest
